Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Piloting an Early Intervention Program for Infants With Rare Neurogenetic Disorders

NCT03836300 is registered in ClinicalTrials.gov with RTI International as lead sponsor.

NCT NCT03836300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03836300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Piloting an Early Intervention Program for Infants With Rare Neurogenetic Disorders
Lead sponsor
RTI International
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
November 30, 2018
Completion date
December 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angelman syndrome, chromosome 22q11.2 deletion syndrome, down syndrome, duchenne muscular dystrophy, dup15q syndrome, fragile x syndrome, klinefelter syndrome, phelan-mcdermid syndrome, prader-willi syndrome, rett syndrome, smith magenis syndrome, tuberous sclerosis, turner syndrome, williams syndrome